LATAM Lions Mane Market Size & Outlook, 2025-2033

LATAM Lions Mane Market Insights

Based on Deep Market Insights findings, the LATAM Lions Mane Market size reached USD 108.36 Million in 2024 and is expected to grow to USD 297.95 Million by 2033.
During 2026–2033, the market is forecasted to advance at a CAGR of 11.78%.
Powders represented the largest share of the Extract forms market in terms of size in 2024.
Among the Extract forms segments, Powders is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.

The global Lions Mane Market size saw LATAM holding a share of 6.02% in 2024.
United States is forecasted to account for the leading share of the global market by 2033.
In LATAM, Colombia is forecasted to be the fastest-expanding market, projected to reach USD 22.33 Million by 2033.

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 108.36 Million
Market Size In 2033	USD 297.95 Million
Largest segment	Powders
Units	Revenue in USD Million
CAGR	11.78% (2025-2033)
Segmnetation Covered
LATAM	Brazil Mexico Argentina Colombia Chile
Extract forms	Powders Liquids Tinctures Standardized extracts
Dosage forms	Capsules Tablets Sachets Gummies
Applications	Nutraceuticals Functional beverages Personal care
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

LATAM	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Brazil	XX.x	XX.x	XX.x	46.66	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Mexico	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Argentina	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Colombia	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Chile	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Extract forms	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Powders	XX.x	XX.x	XX.x	51.16	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Liquids	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Tinctures	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Standardized extracts	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Dosage forms	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Capsules	XX.x	XX.x	XX.x	43.65	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Tablets	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Sachets	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Gummies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Applications	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Nutraceuticals	XX.x	XX.x	XX.x	55.26	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Functional beverages	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Personal care	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x